Otonomy to Participate in Two Upcoming Investor Conferences

Back to Jobs

SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that management will participate in the following virtual investor conference events:

Apply Now